Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$284M Hold
3,125,000
3.15% 14
2026
Q1
$321M Hold
3,125,000
3.96% 14
2025
Q4
$392M Hold
3,125,000
4.2% 12
2025
Q3
$419M Hold
3,125,000
4.56% 10
2025
Q2
$425M Hold
3,125,000
4.91% 9
2025
Q1
$415M Hold
3,125,000
5.18% 8
2024
Q4
$353M Hold
3,125,000
4.27% 12
2024
Q3
$356M Hold
3,125,000
4.34% 11
2024
Q2
$325M Hold
3,125,000
4.15% 15
2024
Q1
$355M Hold
3,125,000
4.27% 12
2023
Q4
$344M Buy
3,125,000
+425,000
+16% +$42.5M 4.26% 10
2023
Q3
$261M Buy
2,700,000
+620,000
+30% +$65.1M 3.48% 16
2023
Q2
$227M Hold
2,080,000
2.99% 18
2023
Q1
$211M Hold
2,080,000
2.94% 19
2022
Q4
$228M Hold
2,080,000
3.38% 18
2022
Q3
$201M Hold
2,080,000
3.15% 18
2022
Q2
$226M Hold
2,080,000
2.95% 20
2022
Q1
$246M Hold
2,080,000
2.57% 22
2021
Q4
$293M Hold
2,080,000
2.78% 22
2021
Q3
$246M Hold
2,080,000
2.43% 22
2021
Q2
$241M Buy
2,080,000
+130,000
+7% +$15.2M 2.3% 22
2021
Q1
$234M Hold
1,950,000
2.44% 21
2020
Q4
$214M Hold
1,950,000
2.18% 21
2020
Q3
$212M Hold
1,950,000
2.87% 20
2020
Q2
$178M Buy
+1,950,000
New +$176M 2.71% 20

Other funds holding ABT

Wellcome Trust's ABT Position: Q2 2026 in Review

Wellcome Trust held its Abbott (ABT) position steady in Q2 2026 at 3,125,000 shares worth $284M. The position accounts for 3.15% of the portfolio, ranked #14.

Wellcome Trust first reported a position in ABT in Q2 2020 and has held it in 25 quarters since. The position peaked at $425M in Q2 2025. 530 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Wellcome Trust held 3,125,000 shares of Abbott worth $284M as of Q2 2026.
  • Wellcome Trust left its Abbott share count unchanged in Q2 2026.
  • Abbott made up 3.15% of Wellcome Trust's portfolio in Q2 2026, its #14 holding.
  • Wellcome Trust first reported a position in Abbott in Q2 2020 and has held it in 25 quarters since.
  • Wellcome Trust's Abbott position peaked at $425M in Q2 2025.
  • 530 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Wellcome Trust's 13F filing for Q2 2026, filed 9 Jul 2026.